Please use this identifier to cite or link to this item:
PIRA download icon_1.1View/Download Full Text
Title: Magnesium implantation or supplementation ameliorates bone disorder in CFTR-mutant mice through an ATF4-dependent Wnt/β-catenin signaling
Authors: Xu, J
Hu, P 
Zhang, X 
Chen, J 
Wang, J
Zhang, J
Chen, Z
Yu, MK 
Chung, YW
Wang, Y
Zhang, X
Zhang, Y
Zheng, N
Yao, H
Yue, J
Chan, HC
Qin, L
Ruan, YC 
Issue Date: Feb-2022
Source: Bioactive materials, Feb. 2022, v. 8, p. 95-108
Abstract: Magnesium metal and its alloys are being developed as effective orthopedic implants; however, the mechanisms underlying the actions of magnesium on bones remain unclear. Cystic fibrosis, the most common genetic disease in Caucasians caused by the mutation of CFTR, has shown bone disorder as a key clinical manifestation, which currently lacks effective therapeutic options. Here we report that implantation of magnesium-containing implant stimulates bone formation and improves bone fracture healing in CFTR-mutant mice. Wnt/β-catenin signaling in the bone is enhanced by the magnesium implant, and inhibition of Wnt/β-catenin by iCRT14 blocks the magnesium implant to improve fracture healing in CFTR-mutant mice. We further demonstrate that magnesium ion enters osteocytes, increases intracellular cAMP level and activates ATF4, a key transcription factor known to regulate Wnt/β-catenin signaling. In vivo knockdown of ATF4 abolishes the magnesium implant-activated β-catenin in bones and reverses the improved-fracture healing in CFTR-mutant mice. In addition, oral supplementation of magnesium activates ATF4 and β-catenin as well as enhances bone volume and density in CFTR-mutant mice. Together, these results show that magnesium implantation or supplementation may serve as a potential anabolic therapy for cystic fibrosis-related bone disease. Activation of ATF4-dependent Wnt/β-catenin signaling in osteocytes is identified as a previously undefined mechanism underlying the beneficial effect of magnesium on bone formation.
Keywords: ATF4
Cystic fibrosis-related bone disorder
Magnesium implant
Wnt signaling
Publisher: Ke Ai Publishing Communications Ltd.
Journal: Bioactive materials 
EISSN: 2452-199X
DOI: 10.1016/j.bioactmat.2021.06.034
Rights: © 2021 THE AUTHORS. Published by Elsevier BV on behalf of Faculty of Engineering, Ain Shams University. This is an open access article under the CC BY-NC-ND license (
The following publication Xu, J., Hu, P., Zhang, X., Chen, J., Wang, J., Zhang, J., . . . Ruan, Y. C. (2022). Magnesium implantation or supplementation ameliorates bone disorder in CFTR-mutant mice through an ATF4-dependent wnt/β-catenin signaling. Bioactive Materials, 8, 95-108 is available at
Appears in Collections:Journal/Magazine Article

Files in This Item:
File Description SizeFormat 
1-s2.0-S2452199X21003200-main.pdf13.62 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
View full-text via PolyU eLinks SFX Query
Show full item record

Page views

Last Week
Last month
Citations as of Nov 22, 2023


Citations as of Nov 22, 2023


Citations as of Dec 1, 2023


Citations as of Nov 30, 2023

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.